FindTrial
Sign In

Study on immune characteristics and clinical outcomes of patients infected with COVID-19 based on different doses of vaccine

Study on immune characteristics and clinical outcomes of patients infected with COVID-19 based on different doses of vaccine

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200057834
Enrollment
Unknown
Registered
2022-03-19
Start date
2022-03-26
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel coronavirus Pneumonia (COVID-19)

Interventions

None listed

Sponsors

Ruijin Hospital, Shanghai Jiao Tong University, School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 65 years; 2. Asymptomatic and mild cases in accordance with the COVID-19 diagnosis and treatment protocol version 9; 3. Subjects who understand and are willing to sign the informed consent and cooperate with the study.

Exclusion criteria

Exclusion criteria: 1. Co-infected with HIV; 2. Co-infected with influenza A and B virus.

Design outcomes

Primary

MeasureTime frame
Coronavirus nucleic acid;—

Secondary

MeasureTime frame
Anxiety questionnaire;Lifestyle Questionnaire;Blood routine test;Blood clotting;Routine urine test;Hepatic function;Renal function;Electrolyte;C-reactive protein;Creatitine;Blood glucose;Glycosylated serum albumin;C-peptide;Cortisol;Aldosterone;Renin;Angiotensin;thyroid function;DIC;Inflammatory factor;Proteomics;Metabonomics;—

Countries

China

Contacts

Public ContactGuang Ning

Ruijin Hospital, Shanghai Jiao Tong University, School of Medicine

61555967@qq.com+86 13918550745

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026